Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs
In Brief: NCI Needs To Move Quicker On Funding Jot New Leads, Rauscher Says; Harley Dirks Quits
Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay
Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter
King Tells Centers To Concentrate On Project Grants
First Lady Helps Dedicate New MDA Facilities
Disease Oriented Programs Must Be Coordinated: Rabson
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO